Ubs Group Ag Sarepta Therapeutics, Inc. Transaction History

Ubs Group Ag

$555 Billion
Q2 2025

A detailed history of Ubs Group Ag transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 501,084 shares of SRPT stock, worth $8.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

501,084

Previous 1,446,458 65.36%

Holding current value

$8.54 Million

Previous $92.3 Million 90.72%

% of portfolio

0.0%

Previous 0.02%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$17.1 - $63.66 $16.2 Million - $60.2 Million	-945,374 Reduced 65.36%	501,084 $8.57 Million
Q1 2025 May 13, 2025	SELL	$63.82 - $127.89 $2.14 Million - $4.29 Million	-33,540 Reduced 2.27%	1,446,458 $92.3 Million
Q4 2024 Feb 14, 2025	BUY	$104.54 - $137.94 $117 Million - $154 Million	1,115,826 Added 306.4%	1,479,998 $180 Million
Q3 2024 Nov 14, 2024	BUY	$124.33 - $156.75 $1.67 Million - $2.1 Million	13,408 Added 3.82%	364,172 $45.5 Million
Q2 2024 Aug 13, 2024	BUY	$113.33 - $163.85 $8.34 Million - $12.1 Million	73,574 Added 26.54%	350,764 $55.4 Million
Q1 2024 May 13, 2024	BUY	$93.7 - $141.53 $85,641 - $129,358	914 Added 0.33%	277,190 $35.9 Million
Q4 2023 Feb 09, 2024	BUY	$67.31 - $124.76 $3.26 Million - $6.04 Million	48,405 Added 21.24%	276,276 $26.6 Million
Q3 2023 Nov 09, 2023	BUY	$102.5 - $123.59 $1.18 Million - $1.43 Million	11,531 Added 5.33%	227,871 $27.6 Million
Q2 2023 Aug 11, 2023	BUY	$106.4 - $157.19 $2.33 Million - $3.45 Million	21,918 Added 11.27%	216,340 $24.8 Million
Q1 2023 May 12, 2023	BUY	$117.53 - $155.99 $3.73 Million - $4.95 Million	31,742 Added 19.51%	194,422 $26.8 Million
Q4 2022 Feb 08, 2023	BUY	$100.86 - $132.13 $9.27 Million - $12.1 Million	91,942 Added 129.98%	162,680 $21.1 Million
Q3 2022 Nov 10, 2022	SELL	$75.71 - $119.24 $3.5 Million - $5.51 Million	-46,200 Reduced 39.51%	70,738 $7.82 Million
Q2 2022 Aug 10, 2022	SELL	$62.69 - $88.44 $2.25 Million - $3.18 Million	-35,935 Reduced 23.51%	116,938 $8.77 Million
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $5.7 Million - $8.16 Million	90,229 Added 144.03%	152,873 $11.9 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $1.23 Million - $1.58 Million	15,913 Added 34.05%	62,644 $5.64 Million
Q3 2021 Nov 15, 2021	BUY	$65.97 - $92.48 $844,152 - $1.18 Million	12,796 Added 37.71%	46,731 $4.32 Million
Q2 2021 Aug 13, 2021	SELL	$69.38 - $86.75 $3.7 Million - $4.62 Million	-53,265 Reduced 61.08%	33,935 $2.64 Million
Q1 2021 May 12, 2021	BUY	$72.25 - $168.95 $1.12 Million - $2.61 Million	15,450 Added 21.53%	87,200 $6.5 Million
Q4 2020 Feb 11, 2021	BUY	$125.56 - $178.74 $614,616 - $874,932	4,895 Added 7.32%	71,750 $12.2 Million
Q3 2020 Nov 12, 2020	BUY	$127.12 - $172.34 $252,968 - $342,956	1,990 Added 3.07%	66,855 $9.39 Million
Q2 2020 Jul 31, 2020	SELL	$93.0 - $171.7 $1.75 Million - $3.23 Million	-18,799 Reduced 22.47%	64,865 $10.4 Million
Q1 2020 May 01, 2020	SELL	$82.38 - $131.64 $273,089 - $436,386	-3,315 Reduced 3.81%	83,664 $8.18 Million
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $8.28 Million - $14.7 Million	-108,252 Reduced 55.45%	86,979 $11.2 Million
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $6.25 Million - $13.5 Million	85,870 Added 78.52%	195,231 $14.7 Million
Q2 2019 Aug 14, 2019	BUY	$112.21 - $151.95 $3.25 Million - $4.4 Million	28,958 Added 36.02%	109,361 $16.6 Million
Q1 2019 May 14, 2019	SELL	$106.67 - $151.68 $477,028 - $678,312	-4,472 Reduced 5.27%	80,403 $9.58 Million
Q4 2018 Feb 14, 2019	BUY	$97.32 - $148.76 $2.23 Million - $3.41 Million	22,929 Added 37.01%	84,875 $9.26 Million
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $3.33 Million - $4.66 Million	-28,870 Reduced 31.79%	61,946 $10 Million
Q2 2018 Aug 14, 2018	SELL	$71.74 - $153.69 $1.23 Million - $2.64 Million	-17,148 Reduced 15.88%	90,816 $12 Million
Q1 2018 May 15, 2018	BUY	$54.02 - $82.27 $1.6 Million - $2.43 Million	29,550 Added 37.68%	107,964 $8 Million
Q4 2017 Feb 14, 2018	SELL	$47.64 - $56.75 $2.69 Million - $3.2 Million	-56,400 Reduced 41.84%	78,414 $4.36 Million
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $1.26 Million - $1.67 Million	35,317 Added 35.5%	134,814 $6.12 Million
Q2 2017 Aug 14, 2017	BUY	N/A	18,053 Added 22.17%	99,497 $3.35 Million
Q1 2017 Nov 14, 2017	BUY	N/A	81,444	81,444 $2.41 Million

Others Institutions Holding SRPT

# of Institutions

463

Shares Held

83.3M

Call Options Held

5.6M

Put Options Held

4.19M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $1.49B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account